Dexmal

DexmalDexmal
D

Dexmal

Developing embodied artificial intelligence to control robots through end-to-end large-model technology.

2025ActiveBeijing, China
Rate

About

Dexmal is a Chinese robotics technology company that develops embodied intelligence software and hardware systems for next-generation smart robots. The company utilizes end-to-end large-model technology, including its proprietary multimodal DM0 foundation model, to enable robots to generalize across diverse productivity applications. Dexmal also provides an open-source vision-language-action toolbox, Dexbotic, and a robot hardware platform, DOS-W1, to support developers in the robotics sector.
Frequently asked

What does Dexmal do?

Dexmal is a Chinese robotics technology company that develops embodied intelligence software and hardware systems for next-generation smart robots. The company utilizes end-to-end large-model technology, including its proprietary multimodal DM0 foundation model, to enable robots to generalize across diverse productivity applications. Dexmal also provides an open-source vision-language-action toolbox, Dexbotic, and a robot hardware platform, DOS-W1, to support developers in the robotics sector.

What is Dexmal's valuation?

StartupHub estimates Dexmal's effective valuation at $1.5B (range $1.1B to $1.9B, 25% confidence), based on comparable companies in the sector.

Where is Dexmal headquartered?

Dexmal is headquartered in Beijing, China.

When was Dexmal founded?

Dexmal was founded in 2025.

What industry does Dexmal operate in?

Dexmal operates in Robotics, Artificial Intelligence, Humanoid Robotics, Embodied AI, AI Agent, Foundation Model.

New entrants in Robotics
Last 90 days
42
New entrants
14.0
Per month
3.3
Per week

An entrant is a company tagged Robotics whose domain was first registered in the window, counted from registry records in the StartupHub directory. 2 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.

Comments

No comments yet. Be the first to share your take.